Morphine Sulfate Capsule, Extended Release
Product Images NDC 0832-0233

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0832-0233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Morphine 01)

FDA Label Image

Figure 1 (Morphine 02)

FDA Label Image

Figure 2 (Morphine 03)

FDA Label Image

Figure 3 (Morphine 04)

FDA Label Image

Figure 4 (Morphine 05)

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Principal Display Panel (10 mg Capsule Bottle Label)
This is a description of Morphine Sulfate Extended-Release Capsules, which come in a 10mg dosage and are provided separately to each patient by a pharmacist. The capsules contain extended-release pellets, and should not be chemed, crushed or dissolved. The package should be stored between 20° to 25°C (66° to 77°F) and is light- and moisture-resistant. It should be kept out of reach of children and dispensed in a sealed, tamper-evident, child-resistant container. The manufacturer is Upsher-Smith Laboratories, LLC located in Maple Grove, MN. Full prescribing information can be found in the set package.*
FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Principal Display Panel (30 mg Capsule Bottle Label)
This is a medicine package for Morphine Sulfate Extended-Release Capsules, USP with each capsule containing 30mg of morphine sulfate as extended-release pellets. Chewing, crushing or dissolving the pellets is NOT recommended. The usual dosage information is provided in the package insert. The package is child-resistant and should be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (50-86°F). The medication must be kept away from moisture and light. A Medication Guide is provided separately with each patient's sealed, tamper-evident, and child-resistant container. This medicine should be dispensed by a pharmacist only and is manufactured by Upsher-Smith Laboratories, LLC.*
FDA Label Image

Principal Display Panel (50 mg Capsule Bottle Label)

Principal Display Panel (50 mg Capsule Bottle Label)
Morphine Sulfate Extended-Release Capsules, USP is a medication containing Morphine Sulfate USP of 50mg in an extended-release pellet form. The usual dosage should be taken as per the prescription. These pellets should not be chewed, crushed or dissolved. The package is child-resistant and should be stored at 20° to 25°C (68° to 77°F); excursions of 50 mg permitted to 15° to 30°C (50° to 86°F). The medication should be kept away from light and moisture. The Pharmacist should dispense the medication guide in a sealed, tamper-evident, child-resistant, provided separately to each patient. Keep out of reach of children. This medication comes in a pack of 100 capsules and is only available with a prescription. It is manufactured by Upsher-Smith Laboratories, LLC in Maple Grove, MN 55369 in the extended-release form to be taken once or twice daily.*
FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Principal Display Panel (60 mg Capsule Bottle Label)
This is a medication called Morphine Sulfate Extended-Release Capsules, USP containing 60mg of morphine in extended-release pellets. The package comes with instructions for typical dosage but should not be chewed, crushed, or dissolved. The container is child-resistant and should be stored between 20° to 25°C (68° to 77°F), with excursions of up to 15° to 30°C (59° to 86°F) permitted. The medication should be protected from light and moisture and dispensed by a pharmacist. The container is tamper-resistant and light-resistant. The medication is only available through a prescription and manufactured by Upsher-Smith Laboratories, LLC in Maple Grove, MN.*
FDA Label Image

Principal Display Panel (80 mg Capsule Bottle Label)

Principal Display Panel (80 mg Capsule Bottle Label)
This is a medication information sheet for Morphine Sulfate Extended-Release Capsules, USP. Each capsule contains Morphine Sulfate, USP 80 mg as extended-release pellets. The recommended dosage should be followed as prescribed. The medication should not be chewed, crushed or dissolved. The package is child-resistant and should be stored at 20° to 25°C (68° to 77°F); excursions of 15° to 30°C (59° to 86°F) are permitted. The medication should be protected from light and moisture. The medication guide should be dispensed by the pharmacist in a sealed, tamper-evident, child-resistant container, provided separately to each patient. The medication should be kept out of reach of children. The manufacturer of the medication is Upsher-Smith Laboratories, LLC.*
FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Principal Display Panel (100 mg Capsule Bottle Label)
Each capsule contains 100 mg of Morphine Sulfate USP as extended-release pellets. The capsules are not to be chewed but rather swallowed whole. The package is child-resistant and should be stored between 20-25°C (68°-77°F) with allowances for excursions of up to 15° to 30°C (59°-86°F). The medication is for use only in Opicid-tolerant patients and should be dispensed in a sealed, tamper-evident, child-resistant container. This medication should be kept out of the reach of children. For complete prescribing information, see the package insert. Manufactured by Upsher-Smith Laboratories, LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.